qRT-PCR showed that the expression of CHRM3-AS2 was significantly higher in glioma cell lines (U251, SHG-44, U87, and T98) than that in HEB cells (P < 0.05, Figure 2A). Here, CHRM3 is linked to central nervous system cancer.